Correction: Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/-catenin/NeuroD1 pathway. Mol Med.
Exendin-4 (Ex-4), a widely used glucagon-like peptide-1 receptor agonist drug in the treatment of T2D, has been demonstrated the therapeutic effects on diabetic encephalopathy (DE). Especially, the Ex-4 ameliorates the tau hyperphosphorylation and cognitive impairment in DE.
Xiaonan Kang's 3 research works with 10 citations and 58 reads, including: Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/-catenin/NeuroD1 pathway.
Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/-catenin/NeuroD1 pathway.Mol. Med.29:118.
Exendin-4 has been shown to cross the blood-brain barrier (BBB) at high doses in mice [20], and exenatide demonstrates the fastest rates of brain inux compared to GLP-1 receptor agonists lixisenatide, liraglutide, and semaglu-tide [21].
Such details provide a deeper understanding and appreciation for Correction Exendin-4 Ameliorates Tau Hyperphosphorylation And.
(2016). Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level.
...depression, anxiety and distress and in ameliorating the quality of life of...
As we can see from the illustration, Correction Exendin-4 Ameliorates Tau Hyperphosphorylation And has many fascinating aspects to explore.
Curcuma Longa ameliorates hemodynamic indices in patients with acute...
